FINNENCE ▪ THE WIRE FILE
THE WIRE · № 64884
News■ Unclear/unknown
Trex Bio Expects IPO Price Between $14.00-$16 Per Share
KINDNews
DIRECTION■ Unclear/unknown
SOURCES2
ENTITIES1
STORY SIZE2 RECORDS
FIRST SEEN2026-10-05 10:36 UTC
LAST UPDATE2026-10-05 10:59 UTC
STATEactive
01 THE MACHINE READ
WHY IT MATTERS.
An IPO pricing range is company-specific and only relevant to biotech new-issue appetite.
Biotech IPO window is being tested
CATALYST TO WATCH
Final pricing and first-day trading
MAIN RISK
Weak demand could chill biotech IPOs
02 THE STORY SO FAR
THE RECORD, IN ORDER.
UPDATED 2 TIMES · FIRST 2026-10-05 10:36 UTC · LAST 2026-10-05 10:59 UTC2026-10-05 10:36 UTCNewsTrex Bio Expects IPO Price Between $14.00-$16 Per Share - SEC Filing - TradingViewCURRENT RECORD
2026-10-05 10:59 UTCNewsTRex Bio files for 8.33M share IPO at $14-$16/sh - Investing.com Nigeria
03 WHO'S INVOLVED
ENTITIES ON FILE.
AFFECTEDHealthcare
04 RECEIPTS
THE SOURCE RECORD.
1 SOURCES CONFIRMED05 PROPAGATION
WHAT THIS TOUCHES.
→CORRELATIONshares Healthcare
TuHURA Biosciences Receives Key U.S. Patent for its Groundbreaking Delta Opioid Receptor (DOR) Antibody Drug Conjugate (ADC) Technology2026-10-05 11:45 UTC
TuHURA Biosciences Receives Key U.S. Patent for its Groundbreaking Delta Opioid Receptor (DOR) Antibody Drug Conjugate (ADC) Technology2026-10-05 11:45 UTC
→CORRELATIONshares Healthcare
Lilly to present new data across its dermatology portfolio with 21 presentations at Fall Clinical 2026, in pursuit of advancing care for chronic skin conditions2026-10-05 11:50 UTC
Lilly to present new data across its dermatology portfolio with 21 presentations at Fall Clinical 2026, in pursuit of advancing care for chronic skin conditions2026-10-05 11:50 UTC
←CORRELATIONshares Healthcare
AnnJi Pharmaceutical Advances AJ201 into Pivotal Phase 3 ROMA-KD Trial for Spinal and Bulbar Muscular Atrophy (SBMA)2026-10-05 04:30 UTC
AnnJi Pharmaceutical Advances AJ201 into Pivotal Phase 3 ROMA-KD Trial for Spinal and Bulbar Muscular Atrophy (SBMA)2026-10-05 04:30 UTC
←CORRELATIONshares Healthcare
Symphony™ Randomized Controlled Trial Demonstrates Significantly Improved Healing of Diabetic Foot Ulcers2026-10-05 04:46 UTC
Symphony™ Randomized Controlled Trial Demonstrates Significantly Improved Healing of Diabetic Foot Ulcers2026-10-05 04:46 UTC
←CORRELATIONshares Healthcare
Anavex Life Sciences Corp. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights2026-10-05 05:38 UTC
Anavex Life Sciences Corp. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights2026-10-05 05:38 UTC
KEEP READING THE MACHINE
Summaries are generated and may contain errors — every claim links its sources.